ng28ÄϹ¬½«ÔÚ2023Äê°¢¶û´Äº£Ä¬²¡Ð­»á¹ú¼Ê¼¯»á£¨AAIC£©ÉÏչʾ°üÀ¨ÂØ¿¨Ä¹ºÍANTI-MTBR TAU¿¹ÌåE2814ÔÚÄÚµÄ×îа¢¶û´Äº£Ä¬²¡²úÆ·ÏߺÍÑо¿½øÕ¹

ng28ÄϹ¬Öêʽ»áÉçÐû²¼£¬½«ÔÚ2023Äê°¢¶û´Äº£Ä¬²¡Ð­»á¹ú¼Ê¼¯»á£¨AAIC£©ÉÏչʾÆä°¢¶û´Äº£Ä¬²¡£¨AD£©²úÆ·ÏߺÍ×îÐÂÑо¿½á¹û£¬°üÀ¨ng28ÄϹ¬ÓÃÓÚÖÎÁÆ°¢¶û´Äº£Ä¬²¡£¨AD£©µÄÂØ¿¨Ä¹£¨LEQEMBI?£©£¬ÒÔ¼°¹«Ë¾ÕýÔÚÑо¿µÄANTI-MTBR TAU¿¹ÌåE2814¡ £¼¯»á½«ÓÚ2023Äê7ÔÂ16ÈÕÖÁ20ÈÕÔÚºÉÀ¼°¢Ä·Ë¹Ìص¤¾ÙÐС£ng28ÄϹ¬½«ÔڸûáÉϽøÐÐ8¸ö¿ÚÍ·±¨¸æºÍ19¸öº£±¨Õ¹Ê¾¡£ÆäÖÐÁ½¸öÔÚAAICÉϵĿÚÍ·±¨¸æ½«Í¬Ê±ÔÚ°¢¶û´Äº£Ä¬²¡³ÉÏñÁªºÏ»á£¨AIC£©ÉÏÒÔº£±¨ÐÎʽ½øÐÐչʾ£¬AIC½«ÓÚ7ÔÂ15ÈÕÓëAAICÔÚͬһËùÔÚ¾ÙÐм¯»á¡£

ng28ÄϹ¬ÃÀ¹ú¸±Ê×ϯÁÙ´²¹Ù¼æADºÍÄÔ½¡¿µÁÙ´²Ñо¿¸ß¼¶¸±×ܲÃMichael Irizarry²©Ê¿ÌåÏÖ£¬”ÔÚAAIC 2023ÉÏ£¬ng28ÄϹ¬½«Õ¹Ê¾¿¹A¦ÂÔ­ÏËά¿¹ÌåÂØ¿¨Ä¹µÄ×îÐÂÊý¾Ý£¬¸Ã¿¹Ìå×î½üÔÚÃÀ¹ú»ñµÃ¹Å°åÅú×¼£¬ÓÃÓÚAD»òÇá¶ÈADËùÖÂÈÏÖªÕÏ°­£¨MCI£©»¼Õß¡£ÂØ¿¨Ä¹Ôڹ㷺µÄÈËȺÖнøÐÐÁËÑо¿£¬ÆäÖаüÀ¨²î±ðÖÖ×åºÍ×åÒáȺÌåÒÔ¼°»¼Óг£¼ûºÏ²¢Ö¢ºÍͬʱ·þÓÃÒ©ÎïµÄ»¼Õß¡£±ðµÄ£¬ng28ÄϹ¬»¹½«Õ¹Ê¾ANTI-MTBR TAU¿¹ÌåE2814µÄÖØÒªÐÂÊý¾Ý£¬¸Ã¿¹ÌåÄ¿Ç°ÕýÔÚ»ªÊ¢¶Ù´óѧʥ·Ò×˹·ÖУµÄÏÔÐÔÒÅ´«ÐÔ°¢¶û´Äº£Ä¬ÊÏÖ¢NTU½øÐÐII/IIIÆÚÁÙ´²ÊÔÑé¡£×÷Ϊng28ÄϹ¬¶Ô͸Ã÷¶ÈµÄÔÊÐíÒÔ¼°ÎÒÃǵÄhhc£¨human health care£¬ÌåÌùÈËÀཡ¿µ£©ºÍ´´Á¢Éú̬ϵͳµÄʹÃüÖеÄÒ»²¿·Ö£¬ÎÒÃǽ«Á¬ÐøչʾºÍÐû²¼ÓйØÎÒÃǵÄAD²úÆ·ÏߺÍÑо¿½øÕ¹·½ÃæµÄÊý¾ÝºÍÐÅÏ¢¡£¡°

 

ng28ÄϹ¬ÔÚAAICÉϽ«Ðû²¼µÄÄÚÈÝÈçÏ£º

ÄϹ¬NG28(Öйú)¹Ù·½ÍøÕ¾-µÇ¼Èë¿Ú

ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉng28ÄϹ¬Ö÷µ¼£¬¶ø²úÆ·ÔòÓÉng28ÄϹ¬ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹã¡£ÆäÖУ¬ng28ÄϹ¬ÓµÓÐ×îÖÕ¾ö²ßȨ¡£

±¾ÐÂΟåÌÖÂÛµÄÊÇÔÚÑÐÖƼÁµÄÑо¿ÓÃ;£¬ÎÞÒâת´ï¹ØÓÚÓÐЧÐÔ»òÄþ¾²ÐԵĽáÂÛ¡£²»°ü¹Ü´ËÀàÑо¿ÓÃÖƼÁ½«ÀÖ³ÉÍê³ÉÁÙ´²¿ª·¢»ò»ñµÃÒ©Æ·¼à¹Ü²¿·ÖµÄÅú×¼¡£

 

ýÌåÁªÂ磺
Eisai Co., Ltd.
Public Relations Department
TEL: +81 (0)3-3817-5120

Eisai Inc. (U.S.)
Libby Holman
+ 1-201-753-1945
Libby_Holman@Eisai.com

Eisai Europe, Ltd.
(UK, Europe, Australia, New Zealand and Russia)
EMEA Communications Department
+44 (0) 786 601 1272
EMEA-comms@eisai.net